Chia‐Yu Chu

12.9k total citations · 7 hit papers
214 papers, 8.0k citations indexed

About

Chia‐Yu Chu is a scholar working on Dermatology, Rheumatology and Immunology and Allergy. According to data from OpenAlex, Chia‐Yu Chu has authored 214 papers receiving a total of 8.0k indexed citations (citations by other indexed papers that have themselves been cited), including 95 papers in Dermatology, 53 papers in Rheumatology and 53 papers in Immunology and Allergy. Recurrent topics in Chia‐Yu Chu's work include Dermatology and Skin Diseases (56 papers), Allergic Rhinitis and Sensitization (44 papers) and Urticaria and Related Conditions (39 papers). Chia‐Yu Chu is often cited by papers focused on Dermatology and Skin Diseases (56 papers), Allergic Rhinitis and Sensitization (44 papers) and Urticaria and Related Conditions (39 papers). Chia‐Yu Chu collaborates with scholars based in Taiwan, United States and Germany. Chia‐Yu Chu's co-authors include Yung‐Tsu Cho, Hsien‐Ching Chiu, J. Wade Harper, Jeffrey Winston, Min‐Liang Kuo, Peggy Beer‐Romero, Stephen J. Elledge, Peter R. Strack, Wen‐Hung Chung and Yi‐Chun Chen and has published in prestigious journals such as New England Journal of Medicine, Proceedings of the National Academy of Sciences and The Lancet.

In The Last Decade

Chia‐Yu Chu

191 papers receiving 7.8k citations

Hit Papers

HLA-B*5801 allele as a ge... 1999 2026 2008 2017 2005 1999 2013 2021 2021 250 500 750
What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

  1. HLA-B*5801 allele as a genetic marker for severe cutaneous adverse reactions caused by allopurinol
    2005 941 citations Wen‐Hung Chung, Wen‐Hung Chung et al. Proceedings of the National Academy of Sciences profile →
  2. The SCFbeta -TRCP-ubiquitin ligase complex associates specifically with phosphorylated destruction motifs in Ikappa Balpha and beta -catenin and stimulates Ikappa Balpha ubiquitination in vitro
    1999 801 citations Chia‐Yu Chu et al. profile →
  3. Drug reaction with eosinophilia and systemic symptoms (DRESS): an original multisystem adverse drug reaction. Results from the prospective RegiSCAR study
    2013 616 citations Chia‐Yu Chu et al. profile →
  4. Once-daily upadacitinib versus placebo in adolescents and adults with moderate-to-severe atopic dermatitis (Measure Up 1 and Measure Up 2): results from two replicate double-blind, randomised controlled phase 3 trials
    2021 350 citations Emma Guttman‐Yassky, Chia‐Yu Chu et al. profile →
  5. Abrocitinib versus Placebo or Dupilumab for Atopic Dermatitis
    2021 287 citations Jonathan I. Silverberg, Chia‐Yu Chu et al. profile →
  6. Two Phase 3 Trials of Lebrikizumab for Moderate-to-Severe Atopic Dermatitis
    2023 162 citations Jonathan I. Silverberg, Emma Guttman‐Yassky et al. profile →
  7. Efficacy and Safety of Upadacitinib in Patients With Moderate to Severe Atopic Dermatitis
    2022 122 citations Chia‐Yu Chu, Jacob P. Thyssen et al. profile →

Author Peers

Peers are selected by citation overlap in the author's most active subfields. citations · hero ref

Author Last Decade Papers Cites
Chia‐Yu Chu 2.5k 2.3k 2.2k 1.9k 1.4k 214 8.0k
Bruce L. Zuraw 402 0.2× 214 0.1× 2.7k 1.2× 1.6k 0.8× 2.7k 2.0× 195 9.4k
Yuan-Tsong Chen 1.3k 0.5× 357 0.2× 1.9k 0.9× 1.1k 0.6× 732 0.5× 51 5.2k
Gilda Varricchi 287 0.1× 396 0.2× 615 0.3× 1.4k 0.7× 3.1k 2.3× 149 6.9k
Michel Malaise 542 0.2× 134 0.1× 4.2k 1.9× 1.9k 1.0× 1.6k 1.2× 202 8.5k
Robert Gniadecki 134 0.1× 4.0k 1.8× 730 0.3× 1.9k 1.0× 3.1k 2.3× 269 8.9k
Kunihiro Yamaoka 258 0.1× 257 0.1× 2.8k 1.3× 1.4k 0.7× 2.5k 1.9× 206 7.2k
P A Bacon 463 0.2× 169 0.1× 5.3k 2.4× 1.5k 0.8× 2.7k 2.0× 194 11.4k
Yoji Nagashima 240 0.1× 288 0.1× 380 0.2× 5.7k 2.9× 840 0.6× 415 11.3k
Joaquín J. Jiménez 164 0.1× 860 0.4× 404 0.2× 2.6k 1.3× 1.3k 1.0× 154 6.0k
Anca I. Catrina 197 0.1× 145 0.1× 4.6k 2.1× 2.1k 1.1× 2.5k 1.8× 135 9.1k

Countries citing papers authored by Chia‐Yu Chu

Since Specialization
Citations

This map shows the geographic impact of Chia‐Yu Chu's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Chia‐Yu Chu with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Chia‐Yu Chu more than expected).

Fields of papers citing papers by Chia‐Yu Chu

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Chia‐Yu Chu. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Chia‐Yu Chu. The network helps show where Chia‐Yu Chu may publish in the future.

Co-authorship network of co-authors of Chia‐Yu Chu

This figure shows the co-authorship network connecting the top 25 collaborators of Chia‐Yu Chu. A scholar is included among the top collaborators of Chia‐Yu Chu based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Chia‐Yu Chu. Chia‐Yu Chu is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
2.
Eichenfield, Lawrence F., Linda Stein Gold, Adelaide A. Hebert, et al.. (2025). Management of Mild‐to‐Moderate Atopic Dermatitis With Topical Treatments by Dermatologists: A Questionnaire‐Based Study. JEADV Clinical Practice. 4(2). 471–481.
3.
4.
Eichenfield, Lawrence F., Linda Stein Gold, Charles Lynde, et al.. (2024). Maintenance of Investigator’s Static Global Assessment Response with Once-Daily Crisaborole in Participants with Mild to Moderate Atopic Dermatitis. Dermatology and Therapy. 14(4). 875–892.
5.
Chu, Chia‐Yu, Siriwan Wananukul, Hao Cheng, et al.. (2024). Management of Moderate-to-Severe Atopic Dermatitis in Adults: A Cross-Sectional Survey of Dermatologists Within the Asia–Pacific Region. Dermatology and Therapy. 14(9). 2559–2576. 1 indexed citations
6.
Kežić, Sanja, Jacob P. Thyssen, Chia‐Yu Chu, et al.. (2024). A Review of Atomic-Force Microscopy in Skin Barrier Function Assessment. Journal of Investigative Dermatology. 144(10). 2136–2144. 1 indexed citations
7.
Chu, Chia‐Yu, Siriwan Wananukul, Hao Cheng, et al.. (2024). Bridging the Gap: Comparing Patient-Clinician Views on Treatment Goals and Communication in the Management of Atopic Dermatitis Within the Asia–Pacific Region. Dermatology and Therapy. 14(8). 2195–2208.
8.
Chu, Chia‐Yu, Siriwan Wananukul, Hao Cheng, et al.. (2024). Quality of Life and Burden of Moderate-to-Severe Atopic Dermatitis in Adult Patients Within the Asia–Pacific Region: A Cross-sectional Survey. Dermatology and Therapy. 14(9). 2479–2493.
9.
Luna, Paula Carolina, et al.. (2023). Psychosocial Burden of Psoriasis: A Systematic Literature Review of Depression Among Patients with Psoriasis. Dermatology and Therapy. 13(12). 3043–3055. 21 indexed citations
10.
Lin, Ming‐Hsien, et al.. (2023). Anatomic mapping of acral melanocytic nevi and acral lentiginous melanomas among Taiwanese patients: A retrospective cohort study. Journal of the Formosan Medical Association. 123(5). 587–593. 1 indexed citations
11.
Luger, Thomas A., et al.. (2023). Pimecrolimus 1% cream for mild-to-moderate atopic dermatitis: a systematic review and meta-analysis with a focus on children and sensitive skin areas. European Journal of Dermatology. 33(5). 474–486. 4 indexed citations
12.
Wu, Chih‐I, Kristina S. Kisel, Yi‐Ting Chen, et al.. (2021). Functionalizing Collagen with Vessel‐Penetrating Two‐Photon Phosphorescence Probes: A New In Vivo Strategy to Map Oxygen Concentration in Tumor Microenvironment and Tissue Ischemia. Advanced Science. 8(20). e2102788–e2102788. 11 indexed citations
13.
Maurer, Marcus, Ana M. Giménez‐Arnau, Jonathan A. Bernstein, et al.. (2021). Sustained safety and efficacy of ligelizumab in patients with chronic spontaneous urticaria: A one‐year extension study. Allergy. 77(7). 2175–2184. 29 indexed citations
14.
Maurer, Marcus, Ana M. Giménez‐Arnau, Luís Felipe Ensina, et al.. (2020). Chronic urticaria treatment patterns and changes in quality of life: AWARE study 2-year results. World Allergy Organization Journal. 13(9). 100460–100460. 42 indexed citations
15.
Chu, Chia‐Yu, Jennifer Choi, Beth Eaby‐Sandy, Corey J. Langer, & Mario E. Lacouture. (2018). Osimertinib: A Novel Dermatologic Adverse Event Profile in Patients with Lung Cancer. The Oncologist. 23(8). 891–899. 32 indexed citations
16.
17.
Chen, Pai‐Sheng, Jen-Liang Su, Woan‐Yuh Tarn, et al.. (2011). miR-107 promotes tumor progression by targeting the let-7 microRNA in mice and humans. Journal of Clinical Investigation. 121(9). 3442–3455. 125 indexed citations
18.
Chen, Pai‐Sheng, Gunnar Johansson, Chia‐Yu Chu, et al.. (2010). MicroRNA-519c Suppresses Hypoxia-Inducible Factor-1α Expression and Tumor Angiogenesis. Cancer Research. 70(7). 2675–2685. 168 indexed citations
19.
Chu, Chia‐Yu, et al.. (2007). Pruritic erythematous plaques over the face, neck, and extremities. Dermatologica Sinica. 25(3). 244–245. 1 indexed citations
20.
Chung, Wen‐Hung, Wen‐Hung Chung, C.C. Chu, et al.. (2005). HLA-B*5801 allele as a genetic marker for severe cutaneous adverse reactions caused by allopurinol. Proceedings of the National Academy of Sciences. 102(11). 4134–4139. 941 indexed citations breakdown →

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Bruce L. Zuraw Breakdown of academic impact, for papers by Yuan-Tsong Chen Breakdown of academic impact, for papers by Gilda Varricchi Breakdown of academic impact, for papers by Michel Malaise Breakdown of academic impact, for papers by Robert Gniadecki Breakdown of academic impact, for papers by Kunihiro Yamaoka Breakdown of academic impact, for papers by P A Bacon Breakdown of academic impact, for papers by Yoji Nagashima Breakdown of academic impact, for papers by Joaquín J. Jiménez Breakdown of academic impact, for papers by Anca I. Catrina
Rankless by CCL
2026